Event Looks At UN High-Level Panel On Medicines Access, SDGs And Policy Coherence 15/07/2017 by Intellectual Property Watch 1 Comment An event on 17 July at the United Nations in New York will address the “UN Secretary General’s High-Level Panel on Access to Medicines: Advancing Health-Related SDGs through Policy Coherence.”
3P Project Enables Radical Change In R&D For TB Treatment 15/07/2017 by Elise De Geyter for Intellectual Property Watch Leave a Comment A new project that stimulates the development of affordable and effective drug regimens to treat tuberculosis (TB) is catching notice in policy circles.
WIPO’s Gurry: Artificial Intelligence, Gene Editing Latest ‘Winners’ In Innovation 13/07/2017 by Elise De Geyter for Intellectual Property Watch Leave a Comment The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation.
Access To Medicines For All By 2030: New WHO Strategic Framework Sets Vision 13/07/2017 by Catherine Saez, Intellectual Property Watch 1 Comment Access to affordable and quality medicines for all is one of the major commitments of the World Health Organization, and its new medicines and health products strategic framework for the next 15 years calls for new research and development (R&D) models, including delinkage of the R&D costs from the price of products, and fair pricing.
Health: Report Calls For Increased Efforts On TB; WHO Warns About Antibiotic-Resistant Sexually Transmitted Disease 07/07/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment Tuberculosis is still a deadly killer, and a new report by two humanitarian organisations raises alarm on poor progress on the disease diagnosis and treatment. The report calls for governments to increase efforts to fight the disease, and for the G20 countries to mobilise funds to help, in particular to boost research and development for new treatments. Separately, the World Health Organization issued a call for new treatments to fight antibiotic resistant gonorrhoea.
New WHO Director Tedros’s Opening Vision: People First 04/07/2017 by William New, Intellectual Property Watch 2 Comments Tedros Adhanom Ghebreyesus began his first week as director-general of the UN World Health Organization by addressing the WHO staff with his vision for the organisation and the world. Top of the list? Humanity.
Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 by Tatum Anderson for Intellectual Property Watch 1 Comment An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year.
Medicines Patent Pool Nets WHO’s Kieny As New Chair 03/07/2017 by Intellectual Property Watch 1 Comment Marie-Paule Kieny, fresh out of the World Health Organization, where she held the position of assistant director general for Health Systems and Innovation, will be the new chair of the Medicines Patent Pool, as of 1 September.
World’s Most Effective HIV Drug Rolled Out In Africa In Generic Version 29/06/2017 by Fredrick Nzwili for Intellectual Property Watch Leave a Comment NAIROBI, Kenya – A generic version of dolutegravir (DTG), the drug of choice for the last two years for people living with HIV in high-income countries, is now available in Africa. On 28 June, the government of Kenya and drug pricing and innovation mechanism Unitaid unveiled the new first-line drug in an effort to accelerate access to better antiretroviral (ARV) drugs for her people living with HIV. It becomes the first country in Africa to introduce the generic version of drug.
Open Access Policy In International Organisations 19/06/2017 by Elise De Geyter for Intellectual Property Watch 3 Comments Open access is “part of the DNA” of international intergovernmental organisations, Charlotte Beauchamp, head of editorial and design at the World Intellectual Property Organization, said during a workshop last week. Representatives of different international organisations described during the workshop the increasing use of an open access policy by their organisations.